Infections  ||| S:0 E:11 ||| NNS
transmitted  ||| S:11 E:23 ||| VBN
from  ||| S:23 E:28 ||| IN
the  ||| S:28 E:32 ||| DT
mother  ||| S:32 E:39 ||| NN
to  ||| S:39 E:42 ||| TO
the  ||| S:42 E:46 ||| DT
fetus ||| S:46 E:51 ||| NN
:  ||| S:51 E:53 ||| :
diagnostic  ||| S:53 E:64 ||| JJ
issues  ||| S:64 E:71 ||| NNS
and  ||| S:71 E:75 ||| CC
management  ||| S:75 E:86 ||| NN
of  ||| S:86 E:89 ||| IN
pregnancy  ||| S:89 E:99 ||| NN
Some  ||| S:99 E:104 ||| DT
infections  ||| S:104 E:115 ||| NNS
are  ||| S:115 E:119 ||| VBP
considered  ||| S:119 E:130 ||| VBN
as  ||| S:130 E:133 ||| IN
feared  ||| S:133 E:140 ||| JJ
risks  ||| S:140 E:146 ||| NNS
during  ||| S:146 E:153 ||| IN
pregnancy ||| S:153 E:162 ||| NN
.  ||| S:162 E:164 ||| .
These  ||| S:164 E:170 ||| DT
infections  ||| S:170 E:181 ||| NNS
may  ||| S:181 E:185 ||| MD
lead  ||| S:185 E:190 ||| VB
to  ||| S:190 E:193 ||| TO
severe  ||| S:193 E:200 ||| JJ
damage  ||| S:200 E:207 ||| NN
of  ||| S:207 E:210 ||| IN
the  ||| S:210 E:214 ||| DT
fetus  ||| S:214 E:220 ||| NN
or  ||| S:220 E:223 ||| CC
the  ||| S:223 E:227 ||| DT
newborn  ||| S:227 E:235 ||| NN
depending  ||| S:235 E:245 ||| VBG
on  ||| S:245 E:248 ||| IN
the  ||| S:248 E:252 ||| DT
infectious  ||| S:252 E:263 ||| JJ
agent  ||| S:263 E:269 ||| NN
and  ||| S:269 E:273 ||| CC
the  ||| S:273 E:277 ||| DT
term  ||| S:277 E:282 ||| NN
of  ||| S:282 E:285 ||| IN
pregnancy  ||| S:285 E:295 ||| NN
where  ||| S:295 E:301 ||| WRB
the  ||| S:301 E:305 ||| DT
infection  ||| S:305 E:315 ||| NN
occurred ||| S:315 E:323 ||| VBD
.  ||| S:323 E:325 ||| .
Antenatal  ||| S:325 E:335 ||| JJ
screening  ||| S:335 E:345 ||| NN
( ||| S:345 E:346 ||| -LRB-
in  ||| S:346 E:349 ||| IN
France  ||| S:349 E:356 ||| NNP
it  ||| S:356 E:359 ||| PRP
concerns  ||| S:359 E:368 ||| VBZ
toxoplasmosis ||| S:368 E:381 ||| VBN
,  ||| S:381 E:383 ||| ,
rubella ||| S:383 E:390 ||| NN
,  ||| S:390 E:392 ||| ,
syphilis  ||| S:392 E:401 ||| NN
and  ||| S:401 E:405 ||| CC
hepatitis  ||| S:405 E:415 ||| NNP
B ||| S:415 E:416 ||| NNP
)  ||| S:416 E:418 ||| -RRB-
play  ||| S:418 E:423 ||| VB
an  ||| S:423 E:426 ||| DT
important  ||| S:426 E:436 ||| JJ
role  ||| S:436 E:441 ||| NN
in  ||| S:441 E:444 ||| IN
prevention  ||| S:444 E:455 ||| NN
and  ||| S:455 E:459 ||| CC
management  ||| S:459 E:470 ||| NN
of  ||| S:470 E:473 ||| IN
vertically  ||| S:473 E:484 ||| RB
transmissible  ||| S:484 E:498 ||| JJ
infections ||| S:498 E:508 ||| NNS
.  ||| S:508 E:510 ||| .
However ||| S:510 E:517 ||| RB
,  ||| S:517 E:519 ||| ,
biological  ||| S:519 E:530 ||| JJ
diagnosis  ||| S:530 E:540 ||| NN
is  ||| S:540 E:543 ||| VBZ
also  ||| S:543 E:548 ||| RB
essential  ||| S:548 E:558 ||| JJ
when  ||| S:558 E:563 ||| WRB
maternal ||| S:563 E:571 ||| JJ
/ ||| S:571 E:572 ||| CD
neo-natal  ||| S:572 E:582 ||| JJ
clinical  ||| S:582 E:591 ||| JJ
symptoms  ||| S:591 E:600 ||| NNS
or  ||| S:600 E:603 ||| CC
abnormal  ||| S:603 E:612 ||| JJ
ultrasound  ||| S:612 E:623 ||| NN
findings  ||| S:623 E:632 ||| NNS
are  ||| S:632 E:636 ||| VBP
observed ||| S:636 E:644 ||| VBN
.  ||| S:644 E:646 ||| .
In  ||| S:646 E:649 ||| IN
this  ||| S:649 E:654 ||| DT
article  ||| S:654 E:662 ||| NN
we  ||| S:662 E:665 ||| PRP
chose  ||| S:665 E:671 ||| VBD
to  ||| S:671 E:674 ||| TO
focus  ||| S:674 E:680 ||| VB
on  ||| S:680 E:683 ||| IN
rubella ||| S:683 E:690 ||| NN
,  ||| S:690 E:692 ||| ,
varicella ||| S:692 E:701 ||| NN
,  ||| S:701 E:703 ||| ,
syphilis ||| S:703 E:711 ||| NN
,  ||| S:711 E:713 ||| ,
toxoplasmosis ||| S:713 E:726 ||| NN
,  ||| S:726 E:728 ||| ,
hepatitis  ||| S:728 E:738 ||| NNP
B  ||| S:738 E:740 ||| NNP
and  ||| S:740 E:744 ||| CC
cytomegalovirus  ||| S:744 E:760 ||| NNS
and  ||| S:760 E:764 ||| CC
parvovirus  ||| S:764 E:775 ||| JJ
infections ||| S:775 E:785 ||| NNS
.  ||| S:785 E:787 ||| .
